FDA Grants Breakthrough Device Designation to AI-Powered Mammogram Analysis Tool for Breast Cancer Risk Prediction

3 Sources

A new AI-based technology developed by Washington University School of Medicine researchers has received FDA Breakthrough Device designation. The software analyzes mammograms to predict a woman's five-year risk of developing breast cancer with improved accuracy.

Breakthrough in Breast Cancer Risk Assessment

A groundbreaking artificial intelligence (AI) technology for analyzing mammograms has received Breakthrough Device designation from the Food and Drug Administration (FDA). Developed by researchers at Washington University School of Medicine in St. Louis, this innovative software aims to significantly improve the accuracy of predicting a woman's personalized five-year risk of developing breast cancer 1.

The Prognosia Breast System

Source: newswise

Source: newswise

The software package, named Prognosia Breast, was created by Dr. Graham A. Colditz and Dr. Shu (Joy) Jiang. It utilizes a pre-trained machine learning system to analyze mammogram images and estimate a patient's likelihood of developing breast cancer over the next five years, based solely on images and the woman's age 2.

According to the developers, Prognosia Breast estimates a person's five-year risk of developing breast cancer 2.5 times more accurately than standard methods, which rely on questionnaires considering factors such as age, race, and family history 3.

Advanced Features and Compatibility

Source: News-Medical

Source: News-Medical

The system is compatible with both 2D full-field digital mammography and 3D digital breast tomosynthesis imaging techniques. It produces an absolute five-year risk score, allowing for comparison with average risk based on national breast cancer incidence rates. This alignment with U.S. national risk reduction guidelines enables clinicians to determine appropriate next steps for women with elevated risk 1.

Potential Impact on Breast Cancer Detection

The new technology could have a significant impact on risk prediction and early detection. With the infrastructure already in place for immediate implementation in mammography centers, it has the potential to reduce the number of late-stage cancer diagnoses. Currently, about 34% of breast cancer patients in the U.S. are diagnosed at later stages of the disease 2.

FDA Breakthrough Device Designation

The FDA Breakthrough Device designation provides an expedited review process for full market approval, aiming to accelerate patient and clinician access to promising new medical devices. This designation is awarded to products that have undergone rigorous testing and shown excellent potential to improve treatment or diagnosis of life-threatening conditions 3.

Source: Medical Xpress

Source: Medical Xpress

Future Prospects and Implementation

Dr. Colditz expressed excitement about the technology's potential to improve risk prediction and prevention of breast cancer globally. The long-term goal is to make this technology available to any woman having a screening mammogram anywhere in the world 2.

The device is intended to complement, not replace, the analysis provided by radiologists. According to guidelines from the American Society of Clinical Oncology and the U.S. Preventive Services Task Force, women with a five-year risk score of 3% or higher are considered to have elevated risk and should be referred to specialists for further advice on additional screening and prevention strategies 1.

Explore today's top stories

Google Unveils Gemini 2.5 Deep Think: A Powerful AI Model for Complex Problem-Solving

Google releases Gemini 2.5 Deep Think, an advanced AI model capable of tackling complex problems through parallel thinking and extended processing time, available exclusively to AI Ultra subscribers.

Ars Technica logoTechCrunch logoCNET logo

19 Sources

Technology

18 hrs ago

Google Unveils Gemini 2.5 Deep Think: A Powerful AI Model

OpenAI Secures $8.3 Billion in Funding, Reaching $300 Billion Valuation

OpenAI raises $8.3 billion in a new funding round, valuing the company at $300 billion. The AI giant's rapid growth and ambitious plans attract major investors, signaling a significant shift in the AI industry landscape.

TechCrunch logoCNBC logoThe New York Times logo

10 Sources

Business and Economy

11 hrs ago

OpenAI Secures $8.3 Billion in Funding, Reaching $300

Reddit's AI-Driven Strategy Boosts Revenue and User Engagement

Reddit's Q2 earnings reveal significant growth driven by AI-powered advertising tools and data licensing deals, showcasing the platform's successful integration of AI technology.

TechCrunch logoReuters logoDataconomy logo

7 Sources

Business and Economy

18 hrs ago

Reddit's AI-Driven Strategy Boosts Revenue and User

Vast Data in Talks for Multibillion-Dollar Funding Round, Potentially Valuing AI Storage Startup at $30 Billion

Vast Data, an AI infrastructure provider, is reportedly in discussions with Alphabet's CapitalG and Nvidia for a significant funding round that could value the company at up to $30 billion, marking a major development in the AI storage sector.

TechCrunch logoReuters logoSiliconANGLE logo

5 Sources

Business and Economy

18 hrs ago

Vast Data in Talks for Multibillion-Dollar Funding Round,

Apple's Record Earnings Overshadowed by Tariff Concerns and AI Challenges

Apple reports strong Q3 2025 earnings with record iPhone sales, but faces ongoing challenges from US tariffs and slow progress in AI development.

Reuters logoTom's Guide logoThe Guardian logo

8 Sources

Business and Economy

19 hrs ago

Apple's Record Earnings Overshadowed by Tariff Concerns and
TheOutpost.ai

Your Daily Dose of Curated AI News

Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Spend less time searching for the latest in AI and get straight to action.

© 2025 Triveous Technologies Private Limited
Instagram logo
LinkedIn logo